Exclusive Agreement with the National Association of Specialty Pharmacy (NASP)
Formulary Insights transformed the payer market research landscape providing a better way to capture and deliver accurate payer insights.
3 Reasons US Payers Will Make 2021 a Banner Year for Biosimilars
Following a year which saw a 143% increase in launched biosimilars in the US, three reasons why payers will drive adoption further in 2021.
For Payer Research, High Stakes are the Mother of All Invention
As payers increasingly stifle new drug launches, investors in biopharmaceutical companies pursue better sources of insights.
A Better Path to Payer Insights
Payers have transformed the competitive marketplace, and biopharma companies need to regain their role as the authority on their products.
Will your clinical trials deliver the leverage you need with payers?
The quality of the clinical evidence will forever be the cornerstone of every payer engagement. Poor integration of payer insights into...
So many market access puzzles to solve and so little time.
That’s why our agile approach works.